Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support

The Trump administration has picked five COVID-19 vaccine candidates that it views as the most likely to be successful, according to an article published Wednesday by The New York Times. The newspaper stated that four of the companies whose candidates made the list are U.S.-based: Moderna (NASDAQ:MRNA), Johnson & Johnson (NYSE:JNJ), Merck (NYSE:MRK), and Pfizer (NYSE:PFE). The other is U.K.-headquartered AstraZeneca (NYSE:AZN), which is partnering with the University of Oxford. Pfizer is also partnering with Germany-based BioNTech (NASDAQ:BNTX). More than 100 organizations and companies are currently working on vaccines to prevent COVID-19.